Lupin Manufacturing Solutions Expands Dabhasa Facility to Bolster Peptide Capabilities
Mumbai, March 19, 2026: Lupin Manufacturing Solutions (LMS), a subsidiary of Lupin Limited, announced a strategic expansion of its Dabhasa manufacturing facility in India. The expansion aims to scale its peptide building-blocks platform and Contract Development and Manufacturing Organization (CRDMO) capabilities.The upgraded facility includes a new block designed to enhance existing CRDMO capabilities, supported by dedicated peptide manufacturing capacity across two specialized units. These enhancements will enable advanced development and flexible manufacturing, catering to the growing global demand for complex pharmaceutical solutions.“As...